Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 27 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Other				186-03 ETH136-03D, NCT00206752


2.		Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 70				Pharmaceutical / Industry				EGF102988 NCT00424255


3.		Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Not specified				Other				7077 NCT00140556


4.		Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Pharmaceutical / Industry				UCIRB #14735B GV-001.010 (TNF-ELF), NCT00496236

Last Modified: 6/17/2008 First Published: 6/23/2003


5.		Phase II Randomized Study of Fruit and Vegetable Extracts in Patients With Stage I-IVB Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				CCCWFU-0112 CCCWFU-60A02, CCCWFU-BG03-161, NCT00064298

Last Modified: 10/16/2008 First Published: 10/25/2004


6.		Phase II Randomized Study of Concurrent Radiotherapy and Chemotherapy Comprising Carboplatin and Paclitaxel With Versus Without Amifostine in Patients With Newly Diagnosed Stage II, III, or IV Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				DFCI-03018 NCT00095927


7.		A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				12652A NCT00203905


8.		Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				06U.195 NCT00358007

First Published: 3/22/2007


9.		Phase II Study of Photodynamic Therapy With Porfimer Sodium in Patients With Pre-Malignant or Malignant Lesions or Condemned Mucosa Syndrome in the Upper Aerodigestive Tract

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Over 18				Other				SCCC-2002103 SCCC-02/618C, SCCC-20050715, SCCC-20020618, NCT00453336


10.		Sorafenib Plus Carboplatin and Paclitaxel in Head and Neck Squamous Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				2006-0940 NCT00494182

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute